2.5200
+0.0700
+(2.86%)
As of 11:06:30 AM EST. Market Open.
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
26,116.8580
45,180.0890
53,320.5810
247.9580
Total Liabilities Net Minority Interest
2,718.4060
2,681.8410
1,900.0800
6.6030
Total Equity Gross Minority Interest
23,398.4520
42,498.2480
51,420.5010
241.3550
Total Capitalization
23,398.4520
42,498.2480
51,420.5010
241.3550
Common Stock Equity
23,398.4520
42,498.2480
51,420.5010
241.3550
Capital Lease Obligations
81.6800
504.3830
--
--
Net Tangible Assets
14,194.2270
32,663.8590
51,420.5010
241.3550
Working Capital
14,058.1140
32,199.0590
52,853.1770
241.3550
Invested Capital
23,398.4520
42,498.2480
51,420.5010
241.3550
Tangible Book Value
14,194.2270
32,663.8590
51,420.5010
241.3550
Total Debt
81.6800
504.3830
--
--
Share Issued
1,041.5820
1,302.1700
1,150.4180
557.8460
Ordinary Shares Number
1,041.5820
1,302.1700
1,150.4180
557.8460
12/31/2020 - 9/15/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LIXT Lixte Biotechnology Holdings, Inc.
2.4566
+2.36%
LGVN Longeveron Inc.
1.6900
+0.60%
IMMX Immix Biopharma, Inc.
2.0000
-2.43%
RLYB Rallybio Corporation
0.8820
+0.23%
ABVC ABVC BioPharma, Inc.
0.5400
+3.13%
ANTX AN2 Therapeutics, Inc.
1.2607
+0.86%
PROK ProKidney Corp.
1.5900
-7.56%
SNPX Synaptogenix, Inc.
3.4700
+0.29%
PMVP PMV Pharmaceuticals, Inc.
1.4200
+3.65%
ZVSA ZyVersa Therapeutics, Inc.
1.4200
-2.07%